Company Overview of ProCertus BioPharm, Inc.
ProCertus BioPharm, Inc., an oncology-based pharmaceutical company, develops therapeutics to protect cancer patients from the side effects of radiotherapy and chemotherapy in the United States. Its products include ProDermaCel that protects cancer patients from chemotherapy- and radiotherapy-induced alopecia; DermX, which prevents radiotherapy-induced dermatitis; and OralX that provides protection against chemotherapy- and radiotherapy- induced oral mucositis. ProCertus BioPharm, Inc. was founded in 1997 and is based in Madison, Wisconsin.
510 Charmany Drive
Suite 175 B
Madison, WI 53719
Founded in 1997
Key Executives for ProCertus BioPharm, Inc.
Similar Private Companies By Industry
|Correlagen Diagnostics, Inc.||United States|
|ICx Biosystems||United States|
|Diversified Bio-Medics, Inc.||United States|
|Abeome Corporation||United States|
|CLINIQA Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Fredericksburg, VA | AstellasPosted: Mar 07
- Princeton, NJ | RGPPosted: Mar 05
- Philadelphia, PA | PwCPosted: Apr 09
- Fresno, CA | AstellasPosted: Feb 20
Sponsored Financial Commentaries
To contact ProCertus BioPharm, Inc., please visit www.procertus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.